Mortality News and Research

RSS

Delays in hospitals' cardiac care services mount during COVID-19 pandemic

Researchers analyzed 94 papers related to the delivery of healthcare services during the COVID-19 pandemic.

7 Dec 2021

Convalescent plasma not recommended for patients with covid-19, WHO experts say

Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline Development Group of international experts in The BMJ today.

7 Dec 2021

Winners of NIH's Decoding Maternal Morbidity Data Challenge announced

The winners of the National Institutes of Health's Decoding Maternal Morbidity Data Challenge were announced today in conjunction with the White House "day of action" on maternal health.

7 Dec 2021

NIH offers $1 million in cash prizes for innovative diagnostics to help improve maternal health

The National Institutes of Health is offering up to $1 million in cash prizes for innovative diagnostic technologies to help improve maternal health around the world in conjunction with the White House "day of action" on maternal health.

7 Dec 2021

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.

7 Dec 2021

Area-level variation in infection fatality ratio in the US COVID-19 pandemic

A new preprint describes the infection fatality ratio, a crucial indicator for planning public health programs and shaping policies.

7 Dec 2021

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

A new study indicates an immunological response to SARS-CoV-2 vaccines in immunosuppressed patients that were comparable to healthy patients.

7 Dec 2021

Study finds mRNA-based COVID-19 vaccines are effective in cancer patients

The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade.

6 Dec 2021

Disparities in maternal mental health during COVID-19

In new research, scientists studied individuals who gave birth during COVID-19. Using propensity score matching (PSM), they matched those identified as either Black or Latinx with those identified as non-Hispanic white on sociodemographic. This recent study published as a preprint on the medRxiv* server attempts to assess the impact of the COVID-19 pandemic on childbirth-related health outcomes in individuals belonging to Black or Latinx minority groups.

6 Dec 2021

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

Researchers performed a retrospective cohort study to determine risk factors for hospitalization and mortality rates over time among COVID-19 patients.

6 Dec 2021

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

Inequalities of the US COVID-19 vaccination drive

The percentage of individuals with at least one dose of a COVID-19 vaccine, by communities, were collected from eight cities to determine US vaccine inequality.

6 Dec 2021

SARS-CoV-2 immune memory in mRNA vaccine recipients

Researchers measured SARS-CoV-2–specific antibody, memory B cell, and memory T cell responses in a group of healthy subjects who generated primary immune responses to two doses of mRNA vaccine compared to a group of SARS-CoV-2–recovered vaccines.

6 Dec 2021

COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

A study recently published in the journal JAMA Oncology has stated that coronavirus disease 2019 (COVID-19) vaccines are more than 55% effective in reducing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients.

5 Dec 2021